Outcome measures for migraine: Measuring the impact of migraine and results of migraine treatment

The experience of migraine symptoms and the impacts of migraine on quality of life (QOL) are best reported by the person experiencing them. Therefore, patient-reported outcome (PRO) measures are often used to collect data about the experience and impact of migraine, and value of migraine treatments....

Full description

Saved in:
Bibliographic Details
Published inHandbook of clinical neurology Vol. 199; pp. 303 - 328
Main Authors Hareendran, Asha, Mannix, Sally
Format Journal Article
LanguageEnglish
Published Netherlands 2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The experience of migraine symptoms and the impacts of migraine on quality of life (QOL) are best reported by the person experiencing them. Therefore, patient-reported outcome (PRO) measures are often used to collect data about the experience and impact of migraine, and value of migraine treatments. PRO concepts that are assessed for the evaluation of migraine treatment outcomes are myriad and diverse (e.g., symptoms, impacts, satisfaction). The first step toward developing a precise strategy to evaluate the outcomes of a treatment is identifying WHAT to measure. This is followed by considerations around HOW to measure the concept. "Selecting What to Measure" section of this chapter discusses the important PRO concepts (WHAT) to measure the impact of migraine and to evaluate interventions for migraine. "Selecting How to Measure" section of this chapter focuses on HOW to collect data about these outcomes in the context of research to evaluate migraine treatments. PRO endpoints recommended in international migraine guidelines and examples of PRO measures that can be used for collecting data to support these endpoints are discussed. The final section of this chapter suggests considerations for selecting PRO measures for evaluating the impact of migraine and migraine treatments and for using these measures to collect data in clinical research.
AbstractList The experience of migraine symptoms and the impacts of migraine on quality of life (QOL) are best reported by the person experiencing them. Therefore, patient-reported outcome (PRO) measures are often used to collect data about the experience and impact of migraine, and value of migraine treatments. PRO concepts that are assessed for the evaluation of migraine treatment outcomes are myriad and diverse (e.g., symptoms, impacts, satisfaction). The first step toward developing a precise strategy to evaluate the outcomes of a treatment is identifying WHAT to measure. This is followed by considerations around HOW to measure the concept. "Selecting What to Measure" section of this chapter discusses the important PRO concepts (WHAT) to measure the impact of migraine and to evaluate interventions for migraine. "Selecting How to Measure" section of this chapter focuses on HOW to collect data about these outcomes in the context of research to evaluate migraine treatments. PRO endpoints recommended in international migraine guidelines and examples of PRO measures that can be used for collecting data to support these endpoints are discussed. The final section of this chapter suggests considerations for selecting PRO measures for evaluating the impact of migraine and migraine treatments and for using these measures to collect data in clinical research.
Author Hareendran, Asha
Mannix, Sally
Author_xml – sequence: 1
  givenname: Asha
  surname: Hareendran
  fullname: Hareendran, Asha
  email: ashavh@hotmail.com
  organization: Patient Centered Research, Evidera, Inc., London, United Kingdom. Electronic address: ashavh@hotmail.com
– sequence: 2
  givenname: Sally
  surname: Mannix
  fullname: Mannix, Sally
  organization: Patient Centered Research, Evidera, Inc., Bethesda, MD, United States
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38307654$$D View this record in MEDLINE/PubMed
BookMark eNpVkDtPwzAUhT0U0Qf8BWQxsbj4kcQxG1S8pKIuMEc39nUJipMSOwP_ngIFielIn75zhjMnk67vkJBzwZeCi-LyxuiScSYkK6VSuWZqyTmXkukJmXGuJTM6l1Myj_GN87w0gh-TqSoV10WezQhsxmT7gDQgxHHASH0_0NBsB2g6vKJP37jptjS9Im3CDmyivf8zKHSO7mtjm-I_ngaEFLBLJ-TIQxvx9JAL8nJ3-7x6YOvN_ePqes12QhaJeWeBoysU2toqAG1Mrm3tUTlvlZDeZ96DE7UqS1eCM3XNFWRoTOGznBdqQS5-dndD_z5iTFVoosW2hQ77MVbSSLkXpfhSzw7qWAd01W5oAgwf1e8t6hMMkGjq
ContentType Journal Article
Copyright Copyright © 2024 Elsevier B.V. All rights reserved, including those for text and data mining, AI training, and similar technologies.
Copyright_xml – notice: Copyright © 2024 Elsevier B.V. All rights reserved, including those for text and data mining, AI training, and similar technologies.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/B978-0-12-823357-3.00022-7
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 328
ExternalDocumentID 38307654
Genre Journal Article
Review
GroupedDBID -~X
.65
0R~
53G
5GY
5JL
5RE
71M
AAGKA
AAKJW
AALRI
AAWMN
AAXUO
AAZNM
ABCQX
ABGTF
ABGWT
ABMAC
ABODX
ABOVZ
ABQQC
ACDGK
ACFHA
ACKCA
ACUJZ
ACXMD
ADTZJ
AEIUV
AEMJY
AEPKO
AFNOJ
AFOST
AFTJW
AHMUE
AIJLT
AJMPQ
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMCAZ
AMINO
AOXUN
AVTBZ
BADUN
BAVGB
BIOBC
BIQZX
BK9
BPGWU
BULYH
BWTMT
BYTKM
CGR
CS3
CUY
CVF
DRRJE
ECM
EDQMI
EIF
FDB
G.I
HZ~
INM
INO
IPQ
IQS
JMC
KYV
LLQQT
MVN
NPM
O9-
OSUHY
QVVOG
RIG
S56
SDK
SES
SHL
7X8
ID FETCH-LOGICAL-p126t-fdca0ed63ecbc3aa79957cbfe3dfc312ff4ffad1b388d8ad9bb03a4e996f45063
ISSN 0072-9752
IngestDate Sat Oct 05 05:25:59 EDT 2024
Sat Nov 02 12:06:53 EDT 2024
IsPeerReviewed true
IsScholarly true
Keywords Acute treatment
Patient-report
Questionnaire
COA
Migraine
Outcome
Instrument
Measure
Preventive treatment
Diary
PRO
Clinical outcome assessment
Language English
License Copyright © 2024 Elsevier B.V. All rights reserved, including those for text and data mining, AI training, and similar technologies.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p126t-fdca0ed63ecbc3aa79957cbfe3dfc312ff4ffad1b388d8ad9bb03a4e996f45063
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
PMID 38307654
PQID 2922450216
PQPubID 23479
PageCount 26
ParticipantIDs proquest_miscellaneous_2922450216
pubmed_primary_38307654
PublicationCentury 2000
PublicationDate 2024-00-00
20240101
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – year: 2024
  text: 2024-00-00
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Handbook of clinical neurology
PublicationTitleAlternate Handb Clin Neurol
PublicationYear 2024
SSID ssj0058910
Score 2.3556995
SecondaryResourceType review_article
Snippet The experience of migraine symptoms and the impacts of migraine on quality of life (QOL) are best reported by the person experiencing them. Therefore,...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 303
SubjectTerms Humans
Migraine Disorders - therapy
Outcome Assessment, Health Care
Patient Reported Outcome Measures
Quality of Life
Treatment Outcome
Title Outcome measures for migraine: Measuring the impact of migraine and results of migraine treatment
URI https://www.ncbi.nlm.nih.gov/pubmed/38307654
https://search.proquest.com/docview/2922450216
Volume 199
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS-QwFA7uCOKLeNld70TYN6nbNk3a-jaKMijjgijr25CkiQrOBacD4q_35FZHdwfUlzIkmVLyfXN6cuZ85yD0SyRaKCpExIpER1lW8ogrbn7umYbXP9FxboTC3QvWuc7ObujNa6NLqy6pxYF8_q-u5CuowhjgalSyn0C2uSkMwGfAF66AMFw_hPGfSQ23Vft9F-izpRX2-_e3pu2D1Zx37URQRL0qIsMal12uxpMHl9LRjDf559POawdWG6fcpqIHRaUtiDkdmu9wk8pTPbrIant81xh-05D5_snFoR98GqkPODiFczCfeRqVOX1rPl2DI28Aia1Y8K9hdjGCI1fPNwEjnBJCwbwd2Ao8UT79JdifUd9CBsfnOGeuyvS7sthh6huaT8HG0Baab59f_j0Pr2HTLdHpj_wzh4qzCfs9-zEW0UK48ewjh3U9rpbRkj8z4LYjwAqaU4NVtND1WRFriHse4MADDDzAActD3LAAAwuwYwEe6mYFBlyxZ8Gb8YYF39H16cnVcSfyrTOiUZKyOtKV5LGqGFFSSMK5KfuXS6EVqbQkSap1pjWvEkGKoip4VQoRE54pOP3qjILb-gO1BsOBWkeYCx4XklImwZNRGQeHPxZcESriopRMbaC9sE89ME3m_yY-UMPJuJeW4B9ScCLZBvrpNrA3cjVUemGXN2fObKFFwz4X7tpGrfpxonbAAazFrof6BTO_WxA
link.rule.ids 315,783,787,4031,27935,27936,27937
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Outcome+measures+for+migraine%3A+Measuring+the+impact+of+migraine+and+results+of+migraine+treatment&rft.jtitle=Handbook+of+clinical+neurology&rft.au=Hareendran%2C+Asha&rft.au=Mannix%2C+Sally&rft.date=2024&rft.issn=0072-9752&rft.volume=199&rft.spage=303&rft_id=info:doi/10.1016%2FB978-0-12-823357-3.00022-7&rft_id=info%3Apmid%2F38307654&rft.externalDocID=38307654
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0072-9752&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0072-9752&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0072-9752&client=summon